• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于医疗保健经济评估中社会视角贬值的一则注释。

A note on the depreciation of the societal perspective in economic evaluation of health care.

作者信息

Johannesson M

机构信息

Stockholm School of Economics, Sweden.

出版信息

Health Policy. 1995 Jul;33(1):59-66. doi: 10.1016/0168-8510(94)00677-7.

DOI:10.1016/0168-8510(94)00677-7
PMID:10143700
Abstract

It is common in cost-effectiveness analyses of health care to only include health care costs, with the argument that some fictive 'health care budget' should be used to maximize the health effects. This paper provides a criticism of the 'health care budget' approach to cost-effectiveness analysis of health care. It is argued that the approach is ad hoc and lacks theoretical foundation. The approach is also inconsistent with using a fixed budget as the decision rule for cost-effectiveness analysis. That is the case unless only costs that fall into a single annual actual budget are included in the analysis, which would mean that any cost paid by the patients should be excluded as well as any future cost changes and all costs that fall on other budgets. Furthermore the prices facing the budget holder should be used, rather than opportunity costs. It is concluded that the 'health care budget' perspective should be abandoned and the societal perspective reinstated in economic evaluation of health care.

摘要

在医疗保健的成本效益分析中,通常只纳入医疗保健成本,理由是应使用某种虚构的“医疗保健预算”来使健康效果最大化。本文对医疗保健成本效益分析中的“医疗保健预算”方法提出了批评。有人认为,该方法是临时特设的,缺乏理论基础。该方法也与将固定预算用作成本效益分析的决策规则不一致。除非分析中只纳入属于单个年度实际预算的成本,这意味着患者支付的任何成本以及未来的成本变化和所有其他预算承担的成本都应排除在外,否则情况就是如此。此外,应该使用预算持有者面临的价格,而不是机会成本。结论是,在医疗保健的经济评估中应摒弃“医疗保健预算”视角,恢复社会视角。

相似文献

1
A note on the depreciation of the societal perspective in economic evaluation of health care.关于医疗保健经济评估中社会视角贬值的一则注释。
Health Policy. 1995 Jul;33(1):59-66. doi: 10.1016/0168-8510(94)00677-7.
2
Cost-utility analysis from a societal perspective.从社会角度进行成本效用分析。
Health Policy. 1997 Mar;39(3):241-53. doi: 10.1016/s0168-8510(96)00878-0.
3
Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis.未来成本、固定医疗保健预算与成本效益分析的决策规则
Health Econ. 2016 Feb;25(2):237-48. doi: 10.1002/hec.3138. Epub 2014 Dec 23.
4
A dollar is a dollar is a dollar--or is it?一美元就是一美元——真的是这样吗?
Value Health. 2006 Sep-Oct;9(5):341-7. doi: 10.1111/j.1524-4733.2006.00123.x.
5
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.预算影响分析——良好实践原则:ISPOR 2012 预算影响分析良好实践 II 工作组报告。
Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13.
6
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.预算影响分析良好实践原则:ISPOR良好研究实践特别工作组——预算影响分析报告
Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x.
7
Economic evaluations and randomized trials in spinal disorders: principles and methods.脊柱疾病的经济学评估与随机试验:原理与方法
Spine (Phila Pa 1976). 2004 Feb 15;29(4):442-8. doi: 10.1097/01.brs.0000102683.61791.80.
8
Cost-effectiveness analysis and capital costs.成本效益分析与资本成本。
Soc Sci Med. 1998 May;46(9):1183-91. doi: 10.1016/s0277-9536(97)10046-6.
9
Economic evaluation of osteoporosis prevention.骨质疏松症预防的经济学评估
Health Policy. 1993 May;24(2):103-24. doi: 10.1016/0168-8510(93)90029-o.
10
The economic evaluation of health care.医疗保健的经济评估。
Health Inf Manag. 1998;28(4):169-72. doi: 10.1177/183335839902800407.

引用本文的文献

1
Cost effectiveness of HIV and sexual reproductive health interventions targeting sex workers: a systematic review.针对性工作者的艾滋病毒和性与生殖健康干预措施的成本效益:一项系统评价
Cost Eff Resour Alloc. 2018 Dec 4;16:63. doi: 10.1186/s12962-018-0165-0. eCollection 2018.
2
Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.医疗资源配置决策:交互干预的联合决策与单独决策。
Med Decis Making. 2018 May;38(4):476-486. doi: 10.1177/0272989X18758018.
3
Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.
术中回收用于产科出血的成本效果分析。
Anesthesiology. 2018 Feb;128(2):328-337. doi: 10.1097/ALN.0000000000001981.
4
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.一个显著的差异?在昂贵药物的经济评估中与有偿和无偿工作相关的生产力成本。
Eur J Health Econ. 2016 May;17(4):391-402. doi: 10.1007/s10198-015-0685-x. Epub 2015 Apr 16.
5
Productivity costs in economic evaluations: past, present, future.经济评估中的生产力成本:过去、现在、未来。
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
6
Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?生命年所获收益中的非直接医疗成本:是否应将其纳入医疗保健干预措施的经济评估中?
Pharmacoeconomics. 2008;26(10):815-30. doi: 10.2165/00019053-200826100-00003.
7
Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions.主张在评估医疗补助处方药干预措施时采用社会视角。
Pharmacoeconomics. 2008;26(4):281-96. doi: 10.2165/00019053-200826040-00002.
8
Common errors and controversies in pharmacoeconomic analyses.
Pharmacoeconomics. 1998 Jun;13(6):659-66. doi: 10.2165/00019053-199813060-00002.
9
Perspectives in economic evaluation.经济评估的视角
BMJ. 1998 May 16;316(7143):1529-30. doi: 10.1136/bmj.316.7143.1529.